article thumbnail

COVID-19 Vaccine Efficacy Reduced With Immunosuppressive, Antiviral HBV Drug Use

HCPLive

Patients taking immunosuppressive and hepatitis B antiviral drugs after living donor liver transplant had lower antibody response to COVID-19 vaccination.

article thumbnail

Post-COVID Transplants, Long COVID Impacts with Kenneth McCurry, MD & Maryam Valapour, MD, MPP

HCPLive

McCurry and Valapour answered several questions on the candidacy of post-infectious COVID-19 patients for lung transplantation and on long COVID. In the latest Lungcast, Drs.

article thumbnail

A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant recipient

Journal of Cardiothoracic Surgery

Coronavirus disease 2019 (COVID-19) infection in lung transplant recipients can be lethal owing to the use of immunosuppressants. Antiviral agents may be administered to these patients. Co-packaged nirmatrelvi.

article thumbnail

Case Report: Combined perioperative extracorporeal membrane oxygenation for acute heart failure caused by mitral regurgitation

Frontiers in Cardiovascular Medicine

ECMO can serve as a bridge to transplant in a chronic setting or as a salvage therapy for patients who are unable to be weaned from bypass following cardiac surgery. In this study, we present the case of a patient who was diagnosed with severe acute onset heart failure secondary to torrential mitral regurgitation following COVID-19 pneumonia.

article thumbnail

ECMO May Offer Sickest COVID Patients Chance for ‘Exceptional Survival’

Society of Thoracic Surgeons - Critical Care

Our work suggests that with appropriately selected patients and aggressive management strategies, the use of ECMO support for severe COVID-19 can result in exceptional early survival, and these patients who leave the hospital without the need for oxygen therapy are very likely to remain alive and well 1 year later,” said Deane E.

article thumbnail

Vaccine myocarditis update from Korea

Dr. Anish Koka

A national study from Korea published in the European Heart Journal sheds important new light on complications related to COVID vaccine related myocarditis. The KDCA also established a reporting system with a legal obligation for special adverse events including myocarditis and pericarditis after COVID-19 vaccination.

article thumbnail

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post?discharge period: The multinational randomized LeoDOR trial

European Journal of Heart Failure

For the global rank score all participants were ranked across three hierarchical groups: Tier 1 = time to death or urgent heart transplantation or implantation of a ventricular assist device; Tier 2 = time to non-fatal HF requiring i.v. Due to the COVID-19 pandemic, the planned number of patients could not be recruited.